Literature DB >> 20852296

Outcomes in patients with cardiovascular implantable electronic devices and bacteremia caused by Gram-positive cocci other than Staphylococcus aureus.

Malini Madhavan1, Muhammad R Sohail, Paul A Friedman, David L Hayes, James M Steckelberg, Walter R Wilson, Larry M Baddour.   

Abstract

BACKGROUND: Infection is a serious complication of cardiovascular implantable electronic device (CIED) placement and requires device removal for attempted cure. METHODS AND
RESULTS: We studied the rate, risk factors, and outcomes of CIED infection in 74 consecutive patients with bacteremia caused by Gram-positive cocci (GPC) other than Staphylococcus aureus between 2001 and 2007. CIED infection was defined as the presence of signs of infection at the generator site, lead vegetations seen on echocardiography, or microbiological growth from device cultures. Twenty-two (30%) of 74 patients with non-S aureus GPC bacteremia had CIED infections. Coagulase-negative staphylococci (CoNS) accounted for 73% of CIED infections. The rate of CIED infection in patients with CoNS bacteremia was almost 2-fold that of non-CoNS GPC bacteremia (36% versus 20%, P = 0.13). The number of leads, the presence of abandoned leads, and prior generator replacement were associated with CIED infection. Among 33 patients without identifiable CIED infection at initial evaluation who did not undergo device removal, 5 (15%) had relapsing bacteremia within 12 weeks of completing antibiotic therapy. CoNS accounted for all relapses, and none had evidence of CIED infection at relapse.
CONCLUSIONS: Patients with a CIED and bacteremia caused by GPC other than S aureus frequently had evidence of underlying CIED infection on clinical evaluation that included transesophageal echocardiography. This was particularly true among those with CoNS bacteremia. No evidence of underlying CIED infections was identified in the subgroup of patients who did not have manifestations of CIED infection on initial evaluation but subsequently had relapsing bacteremia caused by CoNS.

Entities:  

Mesh:

Year:  2010        PMID: 20852296     DOI: 10.1161/CIRCEP.110.957514

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  10 in total

Review 1.  Transvenous Lead Extractions: Current Approaches and Future Trends.

Authors:  Adryan A Perez; Frank W Woo; Darren C Tsang; Roger G Carrillo
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

2.  Cardiac Implantable Electronic Device Infection in Patients at Risk.

Authors:  Khaldoun G Tarakji; Christopher R Ellis; Pascal Defaye; Charles Kennergren
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-05

Review 3.  Nanotechnology-based drug delivery systems for control of microbial biofilms: a review.

Authors:  Matheus Aparecido Dos Santos Ramos; Patrícia Bento Da Silva; Larissa Spósito; Luciani Gaspar De Toledo; Bruna Vidal Bonifácio; Camila Fernanda Rodero; Karen Cristina Dos Santos; Marlus Chorilli; Taís Maria Bauab
Journal:  Int J Nanomedicine       Date:  2018-02-27

4.  Sonication of explanted cardiac implants improves microbial detection in cardiac device infections.

Authors:  Alessandra Oliva; Bich Lien Nguyen; Maria T Mascellino; Alessandra D'Abramo; Marco Iannetta; Antonio Ciccaglioni; Vincenzo Vullo; Claudio M Mastroianni
Journal:  J Clin Microbiol       Date:  2012-11-28       Impact factor: 5.948

5.  European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Carina Blomström-Lundqvist; Vassil Traykov; Paola Anna Erba; Haran Burri; Jens Cosedis Nielsen; Maria Grazia Bongiorni; Jeanne Poole; Giuseppe Boriani; Roberto Costa; Jean-Claude Deharo; Laurence M Epstein; Laszlo Saghy; Ulrika Snygg-Martin; Christoph Starck; Carlo Tascini; Neil Strathmore
Journal:  Europace       Date:  2020-04-01       Impact factor: 5.214

6.  JCS/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias.

Authors:  Akihiko Nogami; Takashi Kurita; Kengo Kusano; Masahiko Goya; Morio Shoda; Hiroshi Tada; Shigeto Naito; Teiichi Yamane; Masaomi Kimura; Tsuyoshi Shiga; Kyoko Soejima; Takashi Noda; Hiro Yamasaki; Yoshifusa Aizawa; Tohru Ohe; Takeshi Kimura; Shun Kohsaka; Hideo Mitamura
Journal:  J Arrhythm       Date:  2022-01-07

7.  Risk of Cardiovascular Implantable Electronic Device Infection in Patients Presenting With Gram-Negative Bacteremia.

Authors:  Supavit Chesdachai; Larry M Baddour; M Rizwan Sohail; Bharath Raj Palraj; Malini Madhavan; Hussam Tabaja; Madiha Fida; Brian D Lahr; Daniel C DeSimone
Journal:  Open Forum Infect Dis       Date:  2022-08-25       Impact factor: 4.423

8.  Influence of the type of pathogen on the clinical course of infectious complications related to cardiac implantable electronic devices.

Authors:  Anna Polewczyk; Wojciech Jacheć; Luca Segreti; Maria Grazia Bongiorni; Andrzej Kutarski
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

9.  Infectious endocardial intracardiac defibrillator lead, infectious pericarditis, and delayed constrictive pericarditis.

Authors:  Mohsen Mir Mohammad Sadeghi; Akbar Sadri; Ahmad Mirdamadi; Mohammad Reza Samiee Nasab; Elham Majidi; Pouya Mir Mohammad Sadeghi
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

10.  Analysis of Outcomes in 8304 Patients Undergoing Lead Extraction for Infection.

Authors:  Ryan G Aleong; Matthew M Zipse; Christine Tompkins; Muhammad Aftab; Paul Varosy; William Sauer; David Kao
Journal:  J Am Heart Assoc       Date:  2020-03-20       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.